TEL AVIV, Israel--(BUSINESS WIRE)--Elron Electronic Industries Ltd. (TASE & NASDAQ: ELRN), announced today that it has completed a new investment of approximately $5.35 million, in two tranches, in Pocared Diagnostics Ltd., an Israeli-based medical device company. The aggregate financing round of $10.7 million was led by Elron and SCP Vitalife Partners II, L.P., a leading medical technology venture capital firm.
